Lab supplies for testing antimicrobial susceptibility of multidrug resistant organisms.
Ended Awarded
- Contract number
- HT009025FG0810089
- Awardee
-
Zuellig Pharma LTD UEI RJ6YHD14GMT1
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $24,045
Award facts
- Contract value 100% obligated
- $24,044.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10110, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency (DHA) awarded a $24,044.58 firm fixed-price Blanket Purchase Agreement (BPA) call to Zuellig Pharma LTD on August 27, 2025, for laboratory supplies to support antimicrobial susceptibility testing of multidrug-resistant organisms. The contract, which has no small business set-aside designation, will be performed in New York, NY and is scheduled for completion by September 30, 2025. This procurement falls under Zuellig Pharma LTD's existing DHA laboratory reagents and medical supplies BPA vehicle, valued at $1.216 million and valid through September 2029, which enables the company to provide consumable medical products and test kits to U.S. government facilities.
Zuellig Pharma LTD, a Thailand-based healthcare services provider registered in SAM.gov since 2014, has established a robust federal contracting portfolio with over 30 awards from defense and health agencies. The company's technical expertise in infectious disease research support and medical laboratory services makes it well-positioned to deliver antimicrobial susceptibility testing supplies, which are critical for identifying drug-resistant pathogens and informing treatment protocols. Beyond the DHA, Zuellig Pharma LTD maintains significant contractual relationships with the U.S. Army Medical Command, Centers for Disease Control and Prevention, Department of State, and Office of the Secretary of Defense, demonstrating consistent capability in supporting U.S. government health and defense objectives.
Quick answers
Who was awarded contract HT009025FG0810089?
HT009025FG0810089 was awarded to Zuellig Pharma LTD by Defense Health Agency (Department of Defense) on August 27, 2025.
How much is contract HT009025FG0810089 worth?
The government has obligated $24,045 on HT009025FG0810089.
Is contract HT009025FG0810089 an order under another contract?
Yes. HT009025FG0810089 is a BPA call under HT942524A0013, a blanket purchase agreement.
Was contract HT009025FG0810089 competed?
The extent of competition for HT009025FG0810089 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award